NASDAQ

Replimune Group, Inc. (REPL)

♥ 631 Thanks from members

Live price chart, market sentiment, and community perspectives for Replimune Group, Inc. (NASDAQ: REPL).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Howard KaufmanFounder: Robert CoffinLeadership: Philip Adams (CEO)Leadership: Howard Kaufman (CMO)Holder: FMR LLCHolder: Baker Bros. AdvisorsHolder: Vanguard GroupRP1RP2RP3Oncolytic immunotherapy pipeline#REPL#Replimune#oncolytic viruses#cancer immunotherapy#biotech